13F Pro quality score
Rank #2,279 of 2,925
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from P3 Health Partners Inc.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $1.5B | $-147.9M | -18.5% |
| FY 2024 | 10-K | $1.5B | $-135.8M | -21.4% |
| FY 2023 | 10-K | $1.3B | $-57.8M | -13.3% |
| FY 2022 | 10-K | $1.0B | $-270.1M | -148.7% |
| FY 2021 | 10-K | $578.6M | $-146.4M | -22.3% |
| FY 2020 | 10-K | $491.1M | $-31.4M | -5.8% |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
P3 Health Partners Inc. (PIII) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PIII at 35.8/100 on a composite quality score built from its SEC filings, placing it at rank #2,279 of 2,925 stocks — the bottom half of the AI-ranked universe. PIII scores in the top quartile across institutional flow (96.5). Areas of concern include earnings quality (4.0) and balance sheet strength (13.9), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), P3 Health Partners Inc. reports quarterly revenue of $386.4M, net income of $7.4M, an operating margin of 10.7%. Top institutional holders of PIII by reported 13-F value include HRT FINANCIAL, JANE STREET GROUP, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. PIII trades on the Nasdaq exchange and files with the SEC under CIK 1832511. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PIII daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for P3 Health Partners Inc. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1832511 →